Table 1.
Clinical and biological characteristics of the NPC patients
| Number of patients | 88 |
|---|---|
|
Gender (Male/Female) |
51/37 |
| |
Median (range) |
|
Age (years) |
46.5 (10.0 – 80.0) |
|
Disease-free survival (months) |
30 (2 – 90) |
|
Overall survival (months) |
36 (2 – 90) |
| |
Number of patients (%) |
|
T – primary tumor extent |
|
| T0 |
0 (0%) |
| T1 |
8 (9.1%) |
| T2 |
25 (28.4%) |
| T3 |
19 (21.6%) |
| T4 |
36 (40.9%) |
|
N – regional lymph nodes |
|
| N0 |
14 (15.9%) |
| N1 |
14 (15.9%) |
| N2 |
28 (31.8%) |
| N3 |
32 (36.4%) |
|
M – distant metastasis |
|
| M0 |
61 (69.3%) |
| M1 |
27 (30.7%) |
|
TNM stage |
|
| I |
2 (2.3%) |
| II |
12 (13.6%) |
| III |
22 (25.0%) |
| IV A |
12 (13.6%) |
| IV B |
13 (14.8%) |
| IV C | 27 (30.7%) |